RECEPTOR TYROSINE KINASE INHIBITORS - Imatinib - STI 571
ATP analogues of the quinazoline/pyridopyrimidine family
compete with ATP for the ATP binding site of the receptor
tyrosine kinase domain.
2003-2004
2003-2004